CEACAM5 and pancreatic neoplasm: A high-affinity head-to-tail dimer of the C9 affibody was designed and compared with clinically validated monoclonal antibodies in immunohistochemical detection of human CEA in frozen as well as FFPE pancreatic cancer patient tissue samples.